Skip to main content
. 2018 Mar 7;22(5):2750–2759. doi: 10.1111/jcmm.13569

Table 1.

Differences in scores variation expressed as median and interquartile range

Baseline Post‐treatment Relative variation P‐valuea P‐valueb
TS Item GERD
CG 63.0 (53.8; 71.0) 38.0 (30.0; 46.0) −0.4 (−0.5; −0.2) <.001 .013
EG 56.5 (47.3; 64.8) 27.5 (19.5; 37.8) −0.5 (−0.7; −0.4)
HS
CG 25.0 (20.3; 27.0) 15.0 (12.0; 19.0) −0.4 (−0.5; −0.2) <.001 <.001
EG 23.5 (20.0; 26.0) 7.0 (4.0; 12.0) −0.7 (−0.9; −0.5)
RS
CG 25.0 (21.3; 27.0) 15.5 (12.0; 18.0) −0.4 (−0.5; −0.3) <.001 <.001
EG 25.0 (21.3; 28.0) 7.5 (4.0; 11.0) −0.7 (−0.8; −0.5)

CG, control group (PPI + TAP water); EG, experimental group (PPI + ERW); TS, total score; HS, heartburn score; RS, regurgitation score; ERW, electrolysed reduced water; PPI, proton pump inhibitors.

a

Effect of time assessed by Friedman's test.

b

Differences between PPI and PPI + ERW therapy group assessed by Mann‐Whitney U‐test.

Bolded P‐values are significant after FDR correction.